Home » Akorn to License Patent From University of Texas M.D. Anderson Cancer Center
Akorn to License Patent From University of Texas M.D. Anderson Cancer Center
Akorn, Inc. announced that it has entered into the agreement to license a patent titled, "M-EDTA Pharmaceutical Preparations of Uses Thereof" (the "Invention") and related technology rights invented by Issam I. Raad and Robert Sheretz. The license grants Akorn the exclusive rights to develop and market the Invention. Previously, on Aug. 24, 2004, Akorn announced that it had entered into an option agreement to license the patent.
Yahoo News (http://biz.yahoo.com/bw/050217/175449_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May